Vascular Solutions (VASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | 24,304 | 22,271 | 21,284 | 20,877 | 19,861 |
| Cost of Goods | 7,463 | 7,571 | 7,228 | 7,076 | 6,932 |
| Gross Profit | 16,841 | 14,700 | 14,056 | 13,801 | 12,929 |
| Operating Expenses | 11,299 | 11,876 | 11,554 | 10,444 | 11,728 |
| Operating Income | 6,005 | 3,395 | 2,730 | 3,433 | 2,133 |
| Interest Expense | 3 | 4 | 3 | 5 | 5 |
| Other Income | -5 | 91 | 43 | -16 | 50 |
| Pre-tax Income | 5,997 | 3,482 | 2,770 | 3,412 | 2,178 |
| Income Tax | 2,287 | 1,323 | 1,059 | -11,560 | 714 |
| Net Income Continuous | 3,710 | 2,159 | 1,711 | 14,972 | 1,464 |
| Net Income | $3,710 | $2,159 | $1,711 | $14,972 | $1,464 |
| EPS Basic Total Ops | 0.22 | 0.13 | 0.10 | 0.91 | 0.09 |
| EPS Basic Continuous Ops | 0.22 | 0.13 | 0.10 | 0.91 | 0.09 |
| EPS Diluted Total Ops | 0.22 | 0.13 | 0.10 | 0.87 | 0.09 |
| EPS Diluted Continuous Ops | 0.22 | 0.13 | 0.10 | 0.88 | 0.09 |
| EBITDA(a) | $6,754 | $4,130 | $3,430 | $4,051 | $2,661 |